VANDA PHARMACEUTICALS INC. Exchange Rate Effect on Cash
VANDA PHARMACEUTICALS INC. (VNDA) reported Exchange Rate Effect on Cash of $40.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents · last filed 2018-02-15
- VANDA PHARMACEUTICALS INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2017-03-31 was $1.00K.
- VANDA PHARMACEUTICALS INC. effect of exchange rate on cash and cash equivalents for fiscal 2017 was $40.00K, a 566.67% increase from fiscal 2016.
- VANDA PHARMACEUTICALS INC. effect of exchange rate on cash and cash equivalents for fiscal 2016 was $6.00K.
| Period end | Effect of Exchange Rate on Cash and Cash Equivalents 3 month | Effect of Exchange Rate on Cash and Cash Equivalents 6 month | Effect of Exchange Rate on Cash and Cash Equivalents 9 month | Effect of Exchange Rate on Cash and Cash Equivalents 12 month |
|---|---|---|---|---|
| 2017-12-31 | $40.00K 10-K · filed 2018-02-15 | |||
| 2017-09-30 | $31.00K 10-Q · filed 2017-11-08 | |||
| 2017-06-30 | $17.00K 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | $1.00K 10-Q · filed 2017-05-03 | |||
| 2016-12-31 | $6.00K 10-K · filed 2018-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |